---
title: "Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296826539.md"
description: "Amgen Inc. (AMGN) shares rose 1.03% to $443.84 on Monday, hitting a new 52-week high. Despite the gain, Amgen underperformed relative to some competitors; Johnson & Johnson rose 1.04%, while Pfizer and AbbVie fell. Trading volume was below the 50-day average. This occurred during a mixed market session where the Dow Jones Industrial Average gained 0.26% and the S&P 500 dropped 0.28%."
datetime: "2026-08-24T20:34:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296826539.md)
  - [en](https://longbridge.com/en/news/296826539.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296826539.md)
generator: "portal-rs"
---

# Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Amgen Inc. (AMGN) rallied 1.03% to $443.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.26% to 53,417.16 and the S&P 500 Index falling 0.28% to 7,652.86.

This was the stock's second consecutive day of gains.

Amgen Inc. hit a new 52-week high, surpassing its previous peak of $443.20, which the company reached on August 19th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 1.04% to $273.04, Pfizer Inc. (PFE) fell 0.36% to $27.97, and AbbVie Inc. (ABBV) fell 0.17% to $264.52.

Trading volume (2.4 M) remained 382,792 below its 50-day average volume of 2.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-24-26 1634ET

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [Strait & Sound Wealth Management LLC Invests $1.92 Million in Amgen Inc. $AMGN](https://longbridge.com/en/news/297400046.md)
- [W1M Asset Management Ltd Acquires Shares of 5,460 AbbVie Inc. $ABBV](https://longbridge.com/en/news/297755003.md)
- [8,321 Shares in Amgen Inc. $AMGN Bought by Glenview Trust Co](https://longbridge.com/en/news/297400065.md)
- [Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Brokerages](https://longbridge.com/en/news/297390790.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**